These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 7852484

  • 1. Extensive personal experience: Paget's disease of bone.
    Siris ES.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):335-8. PubMed ID: 7852484
    [No Abstract] [Full Text] [Related]

  • 2. Paget's disease of bone.
    Haddad JG.
    Curr Ther Endocrinol Metab; 1994 Feb; 5():525-7. PubMed ID: 7704787
    [No Abstract] [Full Text] [Related]

  • 3. 'Breaking the back' of Paget's bone disease.
    Ryan WG.
    Arch Intern Med; 1989 Dec; 149(12):2639. PubMed ID: 2531996
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcitonin or EHDP in Paget's disease?
    Bijvoet OL, Hosking DJ, Van Aken J, Will EJ.
    Calcif Tissue Res; 1977 May; 22 Suppl():494. PubMed ID: 410489
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
    Devogelaer JP, Malghem J, Stasse P, Nagant de Deuxchaisnes C.
    Bone; 1997 Mar; 20(3):259-61. PubMed ID: 9071477
    [Abstract] [Full Text] [Related]

  • 9. Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
    Hosking DJ.
    Metab Bone Dis Relat Res; 1981 Mar; 3(4-5):317-26. PubMed ID: 6820113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
    Alexandre C, Trillet M, Meunier P, Fischer C.
    Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathophysiology and modern management of Paget's disease.
    Ryan WG.
    Compr Ther; 1983 Sep; 9(9):64-9. PubMed ID: 6226475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M, Carrozzo M, Cantatore FP, Scagliusi P, Pipitone V.
    Panminerva Med; 1984 Sep; 26(1):13-7. PubMed ID: 6233523
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ, Gunasekera RD.
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.